Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2003-02-10
2010-06-08
Meller, Michael V (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
07731992
ABSTRACT:
The activity of the enzyme aromatase is inhibited by administering an aromatase inhibiting amount of a composition comprising at least one of astaxanthin, black cohosh, echinacea, and phytosterols to a subject.
REFERENCES:
patent: 4602025 (1986-07-01), Hirsch et al.
patent: 6096307 (2000-08-01), Braswell et al.
patent: 6197309 (2001-03-01), Wheeler
patent: 6217878 (2001-04-01), Menon et al.
patent: 6242012 (2001-06-01), Newmark et al.
patent: 6277417 (2001-08-01), Anderson
patent: 6433025 (2002-08-01), Lorenz
patent: 2003/0008048 (2003-01-01), Winston et al.
patent: 2003/0104076 (2003-06-01), Berkulin et al.
patent: 07041687 (1995-02-01), None
patent: 20011342142 (2001-12-01), None
Kapadia et al., Pharmacological Research, vol. 45, No. 3, 2002, 213-220.
Catchpole et al., Journal of Supercritical Fluids, 22 (2002), 129-138.
Tesch, Clinical Journal of Women's Health, vol. 1, No. 2, Mar. 2001, 89-102.
Tesch, Dis. Mon., Oct. 2002, 48:671-696.
HealthCentral.com, Black Cohosh, 3 pages, 2007.
M. Clemons et al., “Estrogen And The Risk Of Breast Cancer”, The New England Journal of Medicine, Med. vol. 344, No. 4, Jan. 25, 2001.
P. Goss et al., “Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer”, Journal of Clinical Oncology, vol. 19, No. 3, pp. 881-894, Feb. 1, 2001.
J. E. Rossouw et al., “Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women”, Writing Group for the Women's Health Initiative Investigators, JAMA, vol. 288, No. 3, pp. 321-333, Jul. 17, 2002.
J.V. Lacey, Jr., et al., “Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer”, JAMA, vol. 288, No. 3, pp. 334-341, Jul. 17, 2002.
S.W. Fletcher et al., “Failure of Estrogen Plus Progestin Therapy for Prevention”, JAMA, vol. 288, No. 3, pp. 366-368, Jul. 17, 2002.
K. Noller, Estrogen Replacement Therapy And Risk of Ovarian Cancer, JAMA, vol. 288, No. 3, pp. 368-369, Jul. 17, 2002.
Goodman & Gilman's, The Pharmacological Basis of Therapeutics Ed. Hardman & Limbird, 10thEd., McGraw Hill, 2001, pp. 1598-1599.
Mera Pharmaeuticals, Inc., “Astaxanthin Safety for Humans”, 2002.
Fizpatrick, Cella, Harper & Scinto
Meller Michael V
Triarco Industries, Inc.
LandOfFree
Method of inhibiting aromatase with specific dietary... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting aromatase with specific dietary..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting aromatase with specific dietary... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4196902